Please login to the form below
PBMs
This page shows the latest PBMs news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk to cut US insulin prices by up to 75% in January 2024
In January, California attorney general Rob Bonta filed a lawsuit against Novo Nordisk, along with Eli Lilly, Sanofi and leading pharmacy benefit managers (PBMs), for allegedly using their market power to
Latest news
-
California sues largest US insulin manufacturers and PBMs for overpricing
The state of California in the US is suing the nation’s largest insulin manufacturers and pharmacy benefit managers (PBMs) for allegedly using their market power to overcharge patients for the ... With today's lawsuit, we're fighting back against drug
-
FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging
Other attempts to break the Daraprim monopoly included pharmacy benefit manager (PBM) Express Scripts forging a partnership with compounding pharmacy company Imprimis to provide a low-cost alternative.
-
AbbVie/Allergan's merger faces public opposition
Drugmakers have blamed high pricing on rebates demanded by PBMs for inclusion in formularies, while PBMs have insisted this is not the case and that all inclusion decisions are based on
-
Novo follows Sanofi, Lilly with insulin price cut in US
They denied they were responsible, pointing to the complexity of the health insurance system in the US and – in particular – pharmacy benefit managers (PBMs), which the drugmakers claim have a vested ... With PBMs blaming manufacturers for the
-
White House unveils plans to reimport medicines from Canada
This would allow pharma companies to bypass contracts with pharmacy benefit managers (PBMs), but is unlikely to have any takers from pharma, which has been quick to express its strong opposition ... PhRMA had been in support of proposals to ban the
More from news
Approximately 1 fully matching, plus 39 partially matching documents found.
Latest Intelligence
-
Eliminating pharmaceutical rebates, is this déjà vu?
A 2019 report by the GAO (US Government Accountability Office) found that PBMs, or the PBM arm of integrated organisations, were retaining less than 1% of the Medicare Part D rebates ... Whereas in 2012, a survey conducted of health plans and PBM
-
The fight for affordable insulin
In April, in response to growing outrage over the problem (and the wider issue of rising drug prices), executives from pharma companies, pharmacy benefit managers (PBMs) and health insurers were hauled ... We know a lot of their messages align with those
-
The handover: Pfizer reshapes itself for a new era
Read has instead reiterated his support for ending the US rebate system between pharma and pharmacy benefit managers (PBMs) as the best way of lowering prices for patients.
-
The rise of vertical integration in the US payer landscape
But how can manufacturers respond to these new customers? PBM within a payer: Anthem. ... Third, IngenioRx’s goals may differ from those of typical carve-out PBMs.
-
Can new data aggregators shift the balance of power away from pharma?
In the latter case think biotechs and PBMs.) The industry’s strategic response has usually been jump-started by M&A, since organic growth driven by R&D-led changes were
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
PulmoBioMed Wins National Life Science Competition
Dr Moschos’s pioneering work in biomedical sciences and proof of concept funding from Northern Accelerator has led to the creation of an innovative, hand-held breath testing device PBM-Hale. ... PulmoBioMed Chief Operating Officer Jonathan Brookes added
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
